Latest news with #ParagonixKidneyVault™RenalPerfusionSystem
Yahoo
21-04-2025
- Business
- Yahoo
Paragonix Celebrates 100th Kidney Transplant Case with FDA-Cleared KidneyVault™ System
Tennessee Donor Services utilizes Paragonix KidneyVault™ Renal Perfusion System in milestone case. WALTHAM, Mass., April 21, 2025--(BUSINESS WIRE)--Paragonix Technologies, a leader in organ transplant technologies and services, today announced the successful completion of its hundredth case using the FDA-cleared KidneyVault™ Portable Renal Perfusion System. This milestone was achieved with the support of Tennessee Donor Services (TDS), an Organ Procurement Organization (OPO) that serves more than 6 million people across Tennessee and Virginia. In recent years, the transplantation industry has removed geographic barriers to ensure organs may reach those in greatest need, meaning organs now travel farther and remain outside the body longer. For kidney transport, the gold standard of preservation is hypothermic machine perfusion - a clinically accepted therapy that continuously pumps a specialized solution through the organ. The KidneyVault System is the first hypothermic machine perfusion device specifically designed to maximize mobility. The device offers a comprehensive, portable solution from end-to-end, allowing transplant teams to continuously perfuse the kidney and monitor key perfusion metrics in real-time through a mobile-friendly, data-driven dashboard. The innovative system was first used shortly after achieving FDA clearance in late 2024 and has been rapidly adopted by likeminded organizations across the nation ever since. Now, over 12 OPOs stock the device, and 100 donor kidneys have been placed in a KidneyVault for transplant. This rapid adoption reflects a broader shift in the field — one that embraces new technology to meet the evolving demands of organ recovery and allocation. "Tennessee Donor Services' mission is to save and improve lives through organ, eye, and tissue donation, and we're proud of our teams who embrace innovation to save as many lives as possible. It's exciting to partner with Paragonix to be an early adopter of the KidneyVault, a technology that will help more people get their lifesaving transplant, and work alongside their teams to make donation and transplant possible," said Jill Grandas, CEO of Tennessee Donor Services. Leading OPOs like Tennessee Donor Services are leveraging the KidneyVault System to expand access to the limited supply of donor organs and improve post-transplant outcomes. As of April 2025, nearly 90,700 people are on the kidney transplant waiting list in the U.S., representing 86% of the national transplant list. In 2024, 27,761 kidney transplants were performed, highlighting the urgent need for innovative solutions to address the organ shortage. "This hundredth KidneyVault case is a significant milestone for Paragonix and underscores our company's commitment to enhancing the future of organ transplantation," said Dr. Lisa Anderson, President of Paragonix Technologies. "We are proud to offer advanced preservation technologies across all solid organ transplants, and our ability to provide a truly portable renal perfusion system aligns with our mission to provide 'Every Possible Advantage' to those waiting for lifesaving transplants." For more information about Paragonix Technologies, please visit About Tennessee Donor Services An Extraordinary Commitment to Science, Health, and Hope Tennessee Donor Services is a non-profit, organ procurement organization (OPO) dedicated to saving and improving lives by connecting organ and tissue donations to the patients who need them. TDS serves more than six million people in Tennessee and Virginia. About Paragonix Technologies Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to organ preservation. A Getinge company, Paragonix Technologies provides Advanced Organ Preservation ("AOP") devices that safeguard donor organs during the journey between donor and recipient patients. Our FDA-cleared and CE-marked devices incorporate clinically proven and medically trusted cold preservation techniques that allow unprecedented physical and thermal protection to the organ during transit. All Paragonix AOP devices are natively integrated with our novel digital app, delivering real-time organ tracking data and monitoring logistics for transplant teams seeking a secure and centralized solution. For more information, visit Connect with us on LinkedIn: Paragonix Technologies Follow us on Twitter: @ParagonixSherpa Like Us on Facebook: Paragonix SherpaPak View source version on Contacts Media: Adam LafreniereVice President, Marketingmarketing@
Yahoo
03-04-2025
- Health
- Yahoo
Vanderbilt Health Performs First Successful Kidney Transplant Using New Organ Preservation Technology
Vanderbilt University Hospital becomes first hospital in Tennessee to adopt advanced preservation technology for kidney transplantation to expand the donor pool NASHVILLE, Tenn., April 03, 2025--(BUSINESS WIRE)--Paragonix Technologies, Inc., a leader in organ preservation technology, and Vanderbilt Health, one of the oldest and largest kidney transplant programs in the country, are proud to announce the successful transplantation of a donor kidney using the Paragonix KidneyVault™ Renal Perfusion System. The FDA-cleared portable hypothermic perfusion technology is designed to preserve and transport donor kidneys. Vanderbilt is the first in Tennessee, and one of the first in the entire Southeast to use this innovative system for kidney transport. The adoption of KidneyVault is the latest advancement in Vanderbilt's commitment to leveraging cutting-edge technology in the organ transplantation process. By pioneering new approaches, Vanderbilt is able to serve more patients, including high-risk patients who may not be candidates at other medical centers. "We used the technology for transport and pumping and were satisfied with the overall feel and appearance of the kidney at the time of reperfusion," said Christian Crannell, MD, Assistant Professor of Surgery in the Division of Kidney & Pancreas Transplantation. "We also appreciated knowing where the kidney was during transport and knowing the organ temperature." More than 106,000 patients are currently on the national transplant waitlist in the U.S., with 86% waiting for a kidney. Expanding donor pools and optimizing available resources is critical. Hypothermic machine perfusion has shown significant benefits for kidney transplants. KidneyVault's compact and easy-to-transport design combines proven perfusion techniques with advanced digital monitoring, ensuring donor kidneys arrive in optimal condition and improving the process from donation to recipient. "Paragonix is committed to expanding access to donor organs and improving patient outcomes, and we're thrilled to see Vanderbilt Health introduce KidneyVault to its community," said Lisa Anderson, Ph.D., President of Paragonix Technologies. "Innovations like KidneyVault enable transplant centers to accept organs from greater distances and with more logistical complexity than ever before. We look forward to empowering the clinical community to maximize the use of Paragonix devices, giving every donor kidney the best chance to reach a patient in need." For more information about Paragonix Advanced Organ Preservation devices, please visit About Paragonix Technologies Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to organ preservation. A Getinge company, Paragonix Technologies provides Advanced Organ Preservation ("AOP") devices that safeguard donor organs during the journey between donor and recipient patients. Their FDA-cleared and CE-marked devices incorporate clinically proven and medically trusted cold preservation techniques that allow unprecedented physical and thermal protection to the organ during transit. All Paragonix AOP devices are natively integrated with a novel digital app, delivering real-time organ tracking data and monitoring logistics for transplant teams seeking a secure and centralized solution. For more information, visit About Getinge With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile processing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries. Connect with us on LinkedIn: Paragonix Technologies Follow us on X (formerly twitter): @ParagonixSherpa Find us on YouTube: Paragonix SherpaPak View source version on Contacts Media Contact: Adam LafreniereSr. Director, Marketingmarketing@ Sign in to access your portfolio
